FDA officials said an internal analysis found results were not submitted for nearly 30% of studies “highly likely” to fall ...
HaloMD is a middleman that became the top filer of out-of-network billing disputes on behalf of medical providers.
CMS greenlights more than 150 digital health companies for its ACCESS experiment, a new program for tech-backed chronic care ...
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money ...
Landmines ahead for Vinay Prasad’s successor, hospitals and chatbots, and more health news from Morning Rounds ...
Metastatic pancreatic cancer patients who received a targeted pill from Revolution Medicines lived nearly twice as long as patients who got chemotherapy ...
Revolution Medicines 'unprecedented' cancer trial data, Allogene's off-the-shelf CAR-T, and other biotech news ...
The new data bolster Allogene’s efforts to develop a new, easily administered cell therapy that could delay or prevent cancer recurrence.
In a trial, metastatic pancreatic cancer patients on the medicine lived twice as long as those on chemotherapy.
The inflammatory bowel disease therapy succeeded in its first major testing, setting up a competition with several large drugmakers.
As a board-certified urologist who specializes in male sexual dysfunction and men’s health, I often find that people can be pretty dismissive of treatment for erectile dysfuncti ...
A handful of hospitals are launching their own chatbots, a risky bet aimed at better serving current patients and gaining new ones.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results